CV DEATH HAS A NEW OPPONENT
CV DEATH HAS A NEW OPPONENT

Initiating Empagliflozin in HF patients with low eGFR

Document ID: PC-PH-104580

27/03/2023

Author: Boehringer Ingelheim

Related content

 
PC-PH-104580
Production date: March 2023